Skip to main content
SpringerLink
Log in

Intravesical Chemotherapy for Superficial Bladder Cancer

  • Chapter
Chemotherapy and Urological Malignancy

Part of the book series: Clinical Practice in Urology ((PRACTICE UROLOG))

Abstract

One of the major challenges facing the urologist dealing with patients with superficial bladder cancer is the high likelihood that each patient will develop a subsequent tumor despite complete resection of an initial tumor(s). This incidence ranges from 40%–70% and is consistent among several reported series (Greene et al. 1973; Lerman et al. 1970; Pyrah et al. 1964; Williams et al. 1977). Prior to a review of the current status of intravesical therapy, it will be helpful to review the pathology of superficial bladder cancer, critical factors in endoscopic management, and the current concepts regarding the etiology of the high incidence of subsequent tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbassian A, Wallace DM (1966) Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol 96: 461–465

    PubMed  CAS  Google Scholar 

  • Albarran J, Imbert L (1903) Les tumeurs du rein. Masson, Paris, pp 452–459

    Google Scholar 

  • Anderstrdm C, Johansson S, Nilsson S (1980) The significance of lamina propria invasion on the prognosis of patients with bladder tumors. J Urol 124: 23–26

    Google Scholar 

  • Barnes RW, Dick AL, Hadley HL, Johnston OL (1977) Survival following transurethral resection of bladder carcinoma. Cancer Res 37: 2895–2897

    PubMed  CAS  Google Scholar 

  • Boyd PJR, Burnand KG (1974) Site of bladder tumour recurrence. Lancet II: 1290–1292

    Article  Google Scholar 

  • Bracken RB, Johnson DE, von Eschenback AC, Swanson DA, DeFuria MD, Crooke ST (1980) Role of intravesical mitomycin C in management of superficial bladder tumors. Urology 16: 11–15

    Article  PubMed  CAS  Google Scholar 

  • Bubenik J, Perlmann P, Helmstein K, Moberger G (1970) Cellular and humoral immune responses to human urinary bladder carcinomas. In J Cancer 5: 310–319

    CAS  Google Scholar 

  • Burnand KG, Boyd PJR, Mayo ME, Shuttleworth KED, Lloyd-Davies RW (1976) Single-dose intravesical thio-tepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. Br J Urol 48: 55–59

    Article  PubMed  CAS  Google Scholar 

  • Byar D, Blackard C, Veterans Administration Cooperative Urological Research Group (1977) Comparisons of placebo, pyridoxine, and topical thio-tepa in preventing recurrence of stage I bladder cancer. Urology 10: 556–561

    Article  PubMed  CAS  Google Scholar 

  • Colleen S, Ek A, Hellsten S, Lindholm CE (1980) Intravacitary epodyl for multiple, noninvasive, highly differentiated bladder tumours. Scand J Urol Nephrol 14: 43–45

    Article  PubMed  CAS  Google Scholar 

  • Cooper PH, Waisman J, Johnston WH, Skinner DG (1973) Severe atypia of transitional epithelium and carcinoma of the urinary bladder. Cancer 31: 1055–1060

    Article  PubMed  CAS  Google Scholar 

  • Daskal Y, Soloway MS, DeFuria MD, Crooke ST (1980) Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder neoplasms. Cancer Res 40: 261–267

    PubMed  CAS  Google Scholar 

  • Edsmyr F, Boman J (1970) Instillation of thio-tepa (tifosyl) in vesical papillomatosis. Acta Radiol [diagn] (Stockh) 9: 395–400

    CAS  Google Scholar 

  • Edsmyr F, BerlinT, Boman J, DuchekN,Eposti PL, GustafsonH,Wilkstran H (1979) Intravesical therapy with adriamycin in patients with superficial bladder tumours. In: Montedison Lakermedel AB (ed) Diagnostics and treatment of superficial urinary bladder tumours. WHO Collaborating Center for Research and Treatment of Urinary Bladder Cancer, Stockholm, pp 45–54

    Google Scholar 

  • England HF, Paris AMI, Blandy JP (1981) Intravesical thio-tepa as adjuvant to cystodiathermy in multiple recurrent superficial bladder tumours. In: Oliver RDS, Hendry WS, Bloom HJG (eds) Bladder cancer-Principles and combination therapy. Butterworths, London, pp 67–73

    Google Scholar 

  • Farrow GM, Utz DC, Rife CC (1976) Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res 36: 2495–2501

    PubMed  CAS  Google Scholar 

  • Farrow GM, Utz DC, Rife CC, Greene LF (1977) Clinical observations on sixty-nine cases of in-situ carcinoma of the urinary bladder. Cancer Res 37: 2794–2798

    PubMed  CAS  Google Scholar 

  • Fitzpatrick JM, Khan O, Oliver RTD, Riddle PR (1979) Long-term follow up in patients with superficial bladder tumours treated with intravesical epodyl. Br J Urol 51: 545–548

    Article  PubMed  CAS  Google Scholar 

  • Gavrell GJ, Lewis RW, Meehan WL, Leblanc GA (1978) Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder. J Urol 120: 410–411

    PubMed  CAS  Google Scholar 

  • Greene LG, Hanash KA, Farrow GM (1973) Benign papilloma or papillary carcinoma of the bladder? J Urol 110: 205–207

    PubMed  CAS  Google Scholar 

  • Hollands FG (1950) The results of diathermy treatment of villous papilloma of the bladder. Br J Urol 22: 342–375

    Article  PubMed  CAS  Google Scholar 

  • Jacobi GH, Kurth KH, Klippel KF, Hohenfellner R (1979) On the biological behaviour of Tl-transitional cell tumours of the urinary bladder and initial results of the prophylactic use of topical adriamycin under controlled and randomized conditions. In: Montedison Läkermedel AB (ed) Diagnostics and treatment of superficial urinary bladder tumours. WHO Collaborating Center for Research and Treatment of Urinary Bladder Cancer, Stockholm, pp 83–94

    Google Scholar 

  • Jakse G, Hofstadter F, Marberger H (1981) Intracavitary doxorubicin hydrochloride therapy for carcinoma in-situ of the bladder. J Urol 125: 185–190

    PubMed  CAS  Google Scholar 

  • Jewett HG, Strong GH (1946) Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J Urol 55: 366–372

    PubMed  CAS  Google Scholar 

  • Koontz WW Jr, Prout GR Jr, Smith W, Frable WJ, Minnis JE (1981) Use of intravesical thio-tepa in management of non-invasive carcinoma of bladder. J Urol 125: 307–312

    PubMed  Google Scholar 

  • Koss LG, Tiamson EM, Robbins MA (1974) Mapping cancerous and precancerous bladder changes: A study of the urothelium in ten surgically removed bladders. JAMA 227: 281–286

    Article  PubMed  CAS  Google Scholar 

  • Lamm DL, Thor DE, Harris SC, Rayna JA, Stogdill VD, Radwin HM (1980) Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol 124: 38–42

    PubMed  CAS  Google Scholar 

  • Lerman RI, Hutter RVP, Whitmore WFJr(1970) Papilloma of the urinary bladder.Cancer 25:333–342

    Article  PubMed  CAS  Google Scholar 

  • MacKenzie N, Torti FM, Faysa L (1981) Natural history of superficial bladder tumors. Proc Am Assoc Cancer Res 22: 198

    Google Scholar 

  • Marshall VF (1952) The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 68: 714–723

    PubMed  CAS  Google Scholar 

  • Martinez-Pineiro JA (1980) BCG vaccine in the treatment of non-infiltrating papillary tumours of the bladder. In: Pavone-Macaluso M, Smith PH, Edsmyr F (eds) Bladder tumors and other topics in urological oncology. Plenum Press, New York, pp 175–184

    Google Scholar 

  • Martinez-Pineiro JA, Muntanola P (1977) Nonspecific immunotherapy with BCG vaccine in bladder tumors-a preliminary report. Eur Urol 3: 11–22

    PubMed  CAS  Google Scholar 

  • Melicow MM (1952) Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol 68: 261–279

    PubMed  CAS  Google Scholar 

  • Mishina T, Oda K, MurataS, Ooe H, Mori Y, Takahashi T (1975) Mitomycin Cbladder instillation therapy for bladder tumors. J Urol 114: 217–219

    PubMed  CAS  Google Scholar 

  • Morales A (1980) Treatment of carcinoma in-situ of the bladder with BCG. A phase II trial. Cancer Immunol Immunoter 9: 69–72

    Google Scholar 

  • Mukameol E, Zitron S, Nissenkorn I, Servadio C (1980) Prophylactic effect of triethylene thiphasphramide on the recurrence rate of superficial bladder tumors. Isr J Med Sci 16: 714–716

    Google Scholar 

  • Murphy WM, Nagy GK, Rao MK, Soloway MS, Parija GC, Cox CE, Friedell GH (1979) ’Normal’ urothelium in patients with bladder cancer. Cancer 44: 1050–1058

    Article  PubMed  CAS  Google Scholar 

  • Murphy WM, Soloway MS, Lin CJ (1977) Morphologic effects of thio-tepa on mouse urothelium. Acta Cytol (Baltimore) 21: 701–704

    CAS  Google Scholar 

  • Murphy WM, Soloway MS, Lin CJ (1978) Morphologic effects of thio-tepa on mammalian urothelium: Changes in abnormal cells. Acta Cytol (Baltimore) 22: 550–554

    CAS  Google Scholar 

  • Murphy WM, Soloway MS (1980) The effect of thio-tepa on developing and established mammalian bladder tumors. Cancer 45: 870–875

    Article  PubMed  CAS  Google Scholar 

  • Murphy WM, Soloway MS, Crabtree WM (1981) The morphologic effects of mitomycin C in mammalian urinary bladder. Cancer 47: 2567–2574

    Article  PubMed  CAS  Google Scholar 

  • National Bladder Cancer Collaborative Group A, Heney NM, Ahmed S, Flanagan MJ, Frable J, Corder MP, Hafermann MD (1981) Superficial bladder cancer: Progression and recurrence. Presented at AUA Annual Meeting, May 10–14, Boston, Mass

    Google Scholar 

  • Needles B, Blumenreich M, Yagoda A, Sogani P, Whitmore WF (1981) Intravesical cisplatin for superficial bladder cancer. Proc Am Assoc Cancer Res 22: 158, 625

    Google Scholar 

  • Nielsen HV,Thybo E (1979) Epodyl treatment of bladder tumours. Scand J Urol Nephrol 13:59–63

    Article  PubMed  CAS  Google Scholar 

  • Niijima T (1979) Intravesical therapy with adriamycin and new trends in the diagnostics and therapy of superficial urinary bladder tumours. In: Montedison Läkermedel AB (ed) Diagnostics and treatment of superficial urinary bladder tumours. WHO Collaborating Center for Research and Treatment of Urinary Bladder Cancer, Stockholm, pp 37–44

    Google Scholar 

  • Page BH, Levison VB, Curwen MP (1978) The site of recurrence of non-infiltrating bladder tumours. Br J Urol 50: 237–242

    Article  PubMed  CAS  Google Scholar 

  • Pavone-Macaluso M (1971) Chemotherapy of vesical and prostatic tumours. Br J Urol 43:701–708

    Article  PubMed  CAS  Google Scholar 

  • Pavone-Macaluso M (1979) Intravesical treatment of superficial (Tl) urinary bladder tumours: A review of 15-year experience. In: Montedison Läkermedel AB (ed) Diagnostics and treatment of superficial urinary bladder tumours. WHO Collaborating Center for Research and Treatment of Urinary Bladder Cancer, Stockholm, pp 21–36

    Google Scholar 

  • Pavone-Macaluso M, Gebbia N, Biondo F, Bertolini S, Caramia G, Rizzo FP (1976) Permeability of the bladder mucosa to thio-tepa, adriamycin, and daunomycin in men and rabbits. Urol Res 4:9–13

    PubMed  CAS  Google Scholar 

  • Prout GR Jr (1976)The surgical management of bladder carcinoma. Urol Clin North Am 3:149–175

    PubMed  Google Scholar 

  • Pyrah LN, Raper FP, Thomas GM (1964) Report of a follow-up of papillary tumours of the bladder. Br J Urol 36: 14–25

    Article  PubMed  CAS  Google Scholar 

  • Riddle PR, Chisholm GD, Trott PA, Pugh RCB (1976) Flat carcinoma in-situ of bladder. Br J Urol 47: 829–833

    Article  Google Scholar 

  • Riddle PR, Khan O, Fitzpatrick JM, Oliver RTD (1982) Prognostic factors influencing survival of patients receiving intravesical epodyl. J Urol 000: 000–000

    Google Scholar 

  • Robinson MRG, Richards B, Adib R, Akdas A, Rigby CC, Pugh RCB (1980) Intravesical BCT (Bacillus Calmette-Guérin) in the management of Tl, Nx, Mx transitional cell tumors in the bladder: A toxicity study. In: Pavone-Macaluso M, Smith PH, Edsmyr F (eds) Bladder tumors and other topics in urological oncology. Plenum Press, New York, pp 171–174

    Google Scholar 

  • Robinson MRG, Shetty MB, Richard B, Bastable J, Glashan RW, Smith PH (1977) Intravesical epodyl in the management of bladder tumors: Combined experience of the Yorkshire Urological Cancer Research Group. J Urol 118: 972–973

    PubMed  CAS  Google Scholar 

  • Schulman CC, Denis LJ, Oosterlinck W, DeSy W, Chantrie M, Van Cangh J (1981) Early adjuvant adriamycin in superficial bladder cancer. Presented at the AUA Annual Meeting, May 10–14, Boston, Mass

    Google Scholar 

  • Schulman C, Sylvester R, Robinson M, Smith P, Lachand A, Denis L, Pavone-Macaluso M, DePauwM, Staquet M (1979) Adjuvant therapy of Tl bladder carcinoma: Preliminary results of an EORTC randomized study. Recent Results Cancer Res 68: 338–345

    Google Scholar 

  • Soloway MS, Masters S (1980) Urothelial susceptibility to tumor cell implantation-influence of cauterization. Cancer 46: 1158–1163

    Article  PubMed  CAS  Google Scholar 

  • Soloway MS, Murphy WM, DeFuria MD (1981a) Intravesical mitomycin C in superficial bladder cancer. Proc Am Soc Clin Oncol 22: 469

    Google Scholar 

  • Soloway MS, Murphy WM, DeFuria MD, Crooke ST, Finebaum P (1981b) The effect of mitomycin C (MMC) on superficial bladder cancer. J Urol 125: 646–648

    PubMed  CAS  Google Scholar 

  • Soloway MS, Murphy WM, Rao MK, Cox CE (1978) Serial multiple-site biopsies in patients with bladder cancer. J Urol 120: 57–59

    PubMed  CAS  Google Scholar 

  • Soto EA, Friedell GH, Tiltman AJ (1977) Bladder cancer as seen in giant histologic sections. Cancer 39: 447–455

    Article  PubMed  CAS  Google Scholar 

  • Tannenbaum M, Romas NA (1978) The pathobiology of early urothelial cancers. In: Skinner DG, DeKernion JB (eds) Genito-urinary cancer. Saunders, Philadelphia, pp 232–255

    Google Scholar 

  • UICC (1978) TNM classification of malignant tumors, 3rd edn. International Union Against Cancer, Geneva

    Google Scholar 

  • UtzDC, FarrowGM, Rife CC (1980) Carcinoma in-situ of the bladder. Cancer45:1842–1848

    PubMed  CAS  Google Scholar 

  • Utz DC, Hanash KA, Farrow GM (1970) The plight of the patients with carcinoma in-situ of the bladder. J Urol 103: 160

    PubMed  CAS  Google Scholar 

  • Van der Werf-Messing G (1969) Carcinoma of the bladder treated by suprapubic radium implants. Eur J Cancer 5: 277–285

    PubMed  Google Scholar 

  • Veenema RJ, Dean AL Jr, Roberts M, Fingerhurt B, Chowdhury BK, Tarassoly H (1962) Bladder carcinoma treated by direct instillation of thio-tepa. J Urol 88: 60–63

    PubMed  CAS  Google Scholar 

  • Wallace DMA, Hindmarsh JR, Webb JN, Busuttil A, Hargreave TB, Newsam JE, Chisholm GD (1979) The role of multiple mucosal biopsies in the management of patients with bladder cancer. Br J Urol 51: 535–540

    Article  PubMed  CAS  Google Scholar 

  • Williams JL, Hammonds JC, Saunders N (1977) Tl bladder tumours. Br J Urol 49: 663–668

    Article  PubMed  CAS  Google Scholar 

  • Wolf H, Hojgaard K (1980) Urothelial dysplasia in random mucosal biopsies from patients with bladder tumors. Scand J Urol Nephrol 14: 37–41

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. S. Soloway
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Oncology, The Albany Medical College, Albany, New York, 12208, USA

    A. S. D. Spiers MB, BS, MD(Melb.), PhD, FRCPE, FRACP, FACP (Professor of Medicine) (Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Soloway, M.S. (1982). Intravesical Chemotherapy for Superficial Bladder Cancer. In: Spiers, A.S.D. (eds) Chemotherapy and Urological Malignancy. Clinical Practice in Urology. Springer, London. https://doi.org/10.1007/978-1-4471-1332-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1332-4_5

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1334-8

  • Online ISBN: 978-1-4471-1332-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation